Picture of Healius logo

HLS — Healius News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Morgan Stanley upgrades stock rating for Australia's Healius

** Shares of Healius  HLS.AX  rose as much as 8.1% to
A$1.405, their highest level since Nov 17
    ** Analysts at Morgan Stanley see earnings per share risk
for Healius, however, "upon a successful capital raising,
leverage should no longer be an overhang on the shares"
    ** Brokerage upgrades stock rating to "Equal-weight" from
"Underweight"
    ** Morgan Stanley says long-term growth rate assumption of
2.5% remains unchanged; upbeat on co's stock trading near
current price target of A$1.30
    ** One of 10 analysts rate stock "Buy", 7 rate "Hold" and 2
rate "sell" or lower; their median PT is A$1.47 - LSEG data
        ** Stock down 54.3% YTD as of last close

 (Reporting by Shivangi Lahiri in Bengaluru)
 ((Shivangi.Lahiri@thomsonreuters.com;))

Recent news on Healius

See all news